Abstract
The urgent need to scale up testing capacity during the COVID-19 pandemic has prompted the rapid development of point-of-care diagnostic tools such as lateral flow immunoassays (LFIA) for large-scale community-based rapid testing. However, studies of how the general public perform when using LFIA tests in different environmental settings are scarce. This user experience (UX) study of 264 participants in Northern Ireland aimed to gather a better understanding of how self-administered LFIA tests were performed by the general public at home. The UX performance was assessed via analysis of a post-test questionnaire including 30 polar questions and 11 7-point Likert scale questions, which covers the multidimensional aspects of UX in terms of ease of use, effectiveness, efficiency, accuracy and satisfaction. Results show that 96.6% of participants completed the test with an overall average UX score of 95.27% [95% confidence interval (CI) 92.71–97.83%], which suggests a good degree of user experience and effectiveness. Efficiency was assessed based on the use of physical resources and human support received, together with the mental effort of self-administering the test measured via NASA Task Load Index (TLX). The results for six TLX subscales show that the participants scored the test highest for mental demand and lowest for physical demand, but the average TLX score suggests that the general public have a relatively low level of mental workload when using LFIA self-testing at home. Five printed LFIA testing results (i.e. the ‘simulated’ results) were used as the ground truth to assess the participant’s performance in interpreting the test results. The overall agreement (accuracy) was 80.63% [95% CI 75.21–86.05%] with a Kappa score 0.67 [95% CI 0.58–0.75] indicating substantial agreement. The users scored lower in confidence when interpreting test results that were weak positive cases (due to the relatively low signal intensity in the test-line) compared to strong positive cases. The end-users also found that the kit was easier to use than they expected (p < 0.001) and 231 of 264 (87.5%) reported that the test kit would meet their requirements if they needed an antibody testing kit. The overall findings provide an insight into the opportunities for improving the design of self-administered SARS-CoV-2 antibody testing kits for the general public and to inform protocols for future UX studies of LFIA rapid test kits.
Highlights
And accurate diagnostic testing plays an important role in preventing and controlling the spread of COVID-19
Diagnostic tool for COVID-1914–16, there is a lack of user experience (UX) studies that investigate how the lateral flow immunoassays (LFIA) test kits are used by the general public for mass testing in different environmental settings, which is the gap in the literature that this study aimed to fill
The test kit used in this study was the AbC-19 Rapid Test developed by Abingdon Health, which has been approved for professional use in the UK and EU28 and has been used in another UX study for self-administrated LFIA for COVID-19 antibody testing in c ars[26]
Summary
And accurate diagnostic testing plays an important role in preventing and controlling the spread of COVID-19. Results show that errors were found in the sample collection and transfer, as well as difficulties in interpreting the results Another s tudy[17] investigated the usability and performance of seven visual home pregnancy tests that were available in Europe where each device claimed different sensitivity and accuracy scores. A study for usability and acceptability[23] was conducted for self-administered COVID-19 antibody testing in a home environment, which recruited 10,600 and 3800 participants in England for using two types of LFIAs. The presented usability analysis was summarised by descriptive statistics based on data from questionnaires, which identified the difficulties in the use of the lancet, and a need for clearer instructions for using the kit and interpreting the results. Analysis of the free-text responses in the survey suggests that the UX could be improved for blood-sample collection by modifying the method of sample transfer to the test device, and for interpretation of the results by giving clearer instructions
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.